|
|
||||||||
OPEN ACCESS ARTICLE
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STEM CELL GENETICS AND GENOMICS |
aMemorial Sloan-Kettering Cancer Center, New York, New York, USA;
bMax Planck Institute for Experimental Medicine, Goettingen, Germany
Key Words. Adult stem cells • Cancer stem cells • Chromatin • DNA methylation • Embryonic stem cells • Epigenetic control Histones • Pluripotency • Polycomb group proteins • Self-renewal
Correspondence: Vinagolu K. Rajasekhar, M.Sc., M.Phil., Ph.D., Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Rockefeller Research Laboratories, Room #945, New York, New York 10021, USA. Telephone: 646-247-0060; Fax: 212-717-3627; e-mail: vinagolr{at}mskcc.org
Received September 28, 2006;
accepted for publication June 14, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS June 28, 2007.
The acquisition and maintenance of cell fate are essential for metazoan growth and development. A strict coordination between genetic and epigenetic programs regulates cell fate determination and maintenance. Polycomb group (PcG) genes are identified as essential in these epigenetic developmental processes. These genes encode components of multimeric transcriptional repressor complexes that are crucial in maintaining cell fate. PcG proteins have also been shown to play a central role in stem cell maintenance and lineage specification. PcG proteins, together with a battery of components including sequence-specific DNA binding/accessory factors, chromatin remodeling factors, signaling pathway intermediates, noncoding small RNAs, and RNA interference machinery, generally define a dynamic cellular identity through tight regulation of specific gene expression patterns. Epigenetic modification of chromatin structure that results in expression silencing of specific genes is now emerging as an important molecular mechanism in this process. In embryonic stem (ES) cells and adult stem cells, such specific genes represent those associated with differentiation and development, and silencing of these genes in a PcG protein-dependent manner confers stemness. ES cells also contain novel chromatin motifs enriched in epigenetic modifications associated with both activation and repression of genes, suggesting that certain genes are poised for activation or repression. Interestingly, these chromatin domains are highly coincident with the promoters of developmental regulators, which are also found to be occupied by PcG proteins. The epigenetic integrity is compromised, however, by mutations or other alterations that affect the function of PcG proteins in stem cells leading to aberrant cell proliferation and tissue transformation, a hallmark of cancer.
This article has been cited by other articles:
![]() |
F. Sher, R. Rossler, N. Brouwer, V. Balasubramaniyan, E. Boddeke, and S. Copray Differentiation of Neural Stem Cells into Oligodendrocytes: Involvement of the Polycomb Group Protein Ezh2 Stem Cells, November 1, 2008; 26(11): 2875 - 2883. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Gruber, C. Kilgus, A. Mosig, I. L. Hofacker, W. Hennig, and P. F. Stadler Arthropod 7SK RNA Mol. Biol. Evol., September 1, 2008; 25(9): 1923 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Krueger, C. Jeronimo, B. B. Roy, A. Bouchard, C. Barrandon, S. A. Byers, C. E. Searcey, J. J. Cooper, O. Bensaude, E. A. Cohen, et al. LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated Nucleic Acids Res., April 1, 2008; 36(7): 2219 - 2229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Cole, S. E. Johnstone, J. J. Newman, M. H. Kagey, and R. A. Young Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells Genes & Dev., March 15, 2008; 22(6): 746 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Rajasekhar, P. Dalerba, E. Passegue, E. Lagasse, and J. Najbauer The 5th International Society for Stem Cell Research (ISSCR) Annual Meeting, June 2007 Stem Cells, January 1, 2008; 26(1): 292 - 298. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
